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Burkholderia pseudomallei, the causative agent of melioidosis, possesses a
protein-secretion apparatus that is similar to those found in Salmonella and
Shigella. A major function of these secretion systems is to secrete virulence-
associated proteins into target cells of the host organism. The BipD gene of
B. pseudomallei encodes a secreted virulence factor that is similar in sequence
and most likely functionally analogous to IpaD from Shigella and SipD from
Salmonella. Thus, the BipD protein is likely to be a component of a type III
protein-secretion system (TTSS) in B. pseudomallei. Proteins in the same class
as BipD, such as IpaD and SipD, are thought to act as extracellular chaperones
to help the hydrophobic translocator proteins enter the target cell membrane,
where they form a pore and might even link the translocon pore with the
secretion needle. There is evidence that the translocator proteins also bind an
integrin which stimulates actin-mediated insertion of the bacterium into the
host-cell membrane. Native BipD has been crystallized in a monoclinic crystal
form that diffracts X-rays to 2.5 A ˚ resolution. BipD protein which incorporates
selenomethionine (SeMet-BipD) has also been expressed and forms crystals
which diffract to a higher resolution of 2.1 A ˚ .
1. Introduction
Burkholderia pseudomallei and B. mallei are intracellular bacteria
that cause serious invasive infections in animals and are emerging as
major causes of infectious disease in Southeast Asia (Dance, 2002).
These bacteria cause the disease melioidosis, which is endemic to
tropical and subtropical regions, particularly Southeast Asia and
Northern Australia (Gan, 2005). Most commonly, this disease mani-
fests itself clinically as abscesses, pneumonia and, at worst, as a fatal
septicaemia, but has a complex spectrum of clinical manifestations,
making it difﬁcult to diagnose and treat effectively (Aldhous, 2005).
B. pseudomallei is known to infect almost all types of cell and it
appears able to evade and perhaps actively interfere with the host’s
immune system (Gan, 2005). Awareness of B. pseudomallei has
increased in recent years since being identiﬁed and labelled as a
potential biological terrorist weapon (Aldhous, 2005). This attention
has now resulted in the completion of the genome sequence for
B. pseudomallei (Holden et al., 2004). Unlike most bacteria, the
genome comprises two chromosomes of 4.07 and 3.17 Mbp, showing
signiﬁcant functional partitioning of genes between them. The large
chromosome encodes many of the core functions associated with
central metabolism and cell growth, whereas the small chromosome
carries more accessory functions associated with adaptation and
survival in different environments. At 7.24 Mbp, the B. pseudomallei
genome is large in comparison with the typical prokaryotic genome,
perhaps accounting for the bacterium’s versatility and adaptability
(Holden et al., 2004).
Both B. pseudomallei and B. mallei possess a protein-secretion
apparatus that is highly similar to those found in Salmonella and
Shigella (Stevens et al., 2002). A major function of these secretion
systems is to secrete virulence-associated proteins into target cells of
the host organism. Recently, it has been reported that disruption of
the bipD gene, which is within a putative secretion-system locus,
reduces the ability of B. pseudomallei to invade eukaryotic cells and
reduces virulence in mice (Stevens et al., 2002, 2004). The ﬁndings of
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important secreted virulence factor of B. pseudomallei.
BipD is similar in sequence and most likely functionally analogous
to IpaD from Shigella (26% identity) and SipD from Salmonella
(27% identity). Thus, by analogy with these better studied organisms,
the BipD protein is likely to be a component of a type III protein-
secretion system (TTSS) in B. pseudomallei. TTSSs are large
assemblies of proteins that span the inner bacterial membrane, the
periplasmic space, the peptidoglycan layer, the outer bacterial
membrane, the extracellular space and the target-cell membrane (Yip
& Strynadka, 2006). The function of bacterial protein-secretion
systems is to transport ‘effector’ and other proteins across the
bacterial inner membrane and the outer envelope (Mecsas & Strauss,
1996) in an ATP-dependent manner. There are ﬁve systems (types I–
V) which operate in different ways and vary in complexity. Some
involve a hollow tube or needle (the injectisome) through which the
secreted proteins travel (Mota et al., 2005). The TTSS injectisome
varies between 45 and 80 nm in length depending on the bacterial
species, is made by the polymerization of a major subunit and has a
hollow interior of approximately 25 A ˚ in diameter. The ring-like
assembly that spans the membrane of thehost cell is referred to asthe
translocon. This is formed by the initial secretion of a small number of
proteins into the extracellular environment as a result of contact
between the bacterium and the target cell (Pettersson et al., 1996).
The translocator proteins act to transport bacterial proteins across
the plasma membrane into the host cell, which are then able to
subvert or inhibit the cell’s processes for the beneﬁt of the bacterium.
It appears that the translocator proteins form a pore in the lipid
membrane of the target cell through which the effector proteins are
able to pass (Blocker et al., 2000).
It has been found that B. pseudomallei contains at least three loci
encoding putative type III protein-secretion systems (Rainbow et al.,
2002), one of which shares homology with the TTSS of Salmonella
typhimurium (Attree & Attree, 2001) and Shigella ﬂexneri (Stevens et
al., 2002) and has been designated BSA (short for Burkholderia
secretion apparatus; Hueck, 1998). The BSA effector proteins are
termed Bop proteins and the translocators are termed Bip proteins,
short for Burkholderia invasion proteins. In Salmonella, SipB, SipC
and SipD have been shown to be required for the injection of effector
proteins and the invasion of epithelial cells in vitro (Kaniga et al.,
1995) and likewise for IpaB, IpaC and IpaD from Shigella (Me ´nard et
al., 1994). Hence, it is thought that the B. pseudomallei homologues
BipB, BipC and BipD perform a similar function.
Serum from melioidosis victims contains antibodies to BipD and
the other putative translocator proteins. It has been shown that
B. pseudomallei bacteria with mutated BipD show reduced virulence
but are still able to cause fatal melioidosis (Stevens et al., 2004). The
BipD mutant exhibited impaired invasion of HeLa cells and reduced
intracellular survival in murine macrophage-like cells and a marked
reduction in actin-tail formation (Stevens et al., 2002, 2004). Hence,
there is evidence that BipD is involved in the actin polymerization
that facilitates the escape of B. pseudomallei from endocytic vesicles
during the initial infection and the subsequent escape of progeny
bacteria into surrounding host cells. Observations made during these
experiments support the idea that a functional TTSS is required for
full virulence of B. pseudomallei. It has been suggested that proteins
in the same class as BipD (i.e. IpaD and SipD) act as extracellular
chaperones to help the hydrophobic translocators (equivalent to
BipB and BipC) enter the target-cell membrane and might even link
the translocon pore with the secretion needle (Mecsas & Strauss,
1996). Since IpaD, as a complex with the hydrophobic translocators
IpaB and IpaC, can bind the 51 integrin, stimulating the phos-
phorylation of a focal adhesion kinase (Watarai et al., 1996), it is
possible that BipD acts in a similar way to aid actin-mediated inser-
tion of the bacterium into the host-cell membrane.
The BipD protein from B. pseudomallei consists of 310 amino acids
and has a molecular weight of 33 kDa. We have crystallized BipD in a
monoclinic crystal form that diffracts X-rays to 2.5 A ˚ resolution. We
have also expressed BipD protein which incorporates seleno-
methionine (SeMet-BipD) for MAD data collection. The latter
protein gave crystals of the same form which diffracted to an
improved resolution of 2.1 A ˚ .
2. Overexpression, purification and crystallization of native
and selenomethionyl-BipD
We have generated a pGEX-4T (Pharmacia) plasmid construct
encoding a fusion of BipD with glutathione-S-transferase (GST) to
facilitate expression in Escherichia coli and puriﬁcation by use of a
GSTrap afﬁnity column (GE Healthcare). Crystals of native BipD
were obtained using the hanging-drop method with 5 ml of protein
being mixed with 5 ml of each well solution on siliconized glass cover
slips. The optimum well solution for crystallization consisted of 25%
PEG 4000, 5 mM nickel chloride, 0.1 M glycine, 0.1 M sodium caco-
dylate pH 6.5. Crystals appeared after approximately nine weeks at
either 277 or 295 K and were cryoprotected with 30% glycerol and
mounted in mohair loops for ﬂash-freezing in liquid ethane and
storage under liquid nitrogen.
Initial attempts to express selenomethionyl-BipD (SeMet-BipD)
involved growth of the cells on the 2 l scale to mid-log phase in LB
medium (including 50 mgm l
1 ampicillin) followed by centrifugation
to pellet them. The cells were resuspended in M9 minimal medium
(containing ampicillin at the same concentration and 0.4% glucose)
and grown for another 45 min to use up remaining amino acids. The
cultures were then inoculated with the vitamins riboﬂavin, niacin-
amide, pyridoxine and thiamine each at ﬁnal concentrations of
1m gl
1 and a mixture of all 20 amino acids each at ﬁnal concen-
trations of 40 mg l
1 except for methionine, which was replaced by
selenomethionine. The cells were then shaken at 310 K for another
20 min prior to overnight induction with 1 mM isopropyl--d-thio-
galactopyranoside (IPTG). This procedure has the advantage of
avoiding the use of a methionine-auxotrophic strain of E. coli.
However, whilst with trial cultures SDS–PAGE had shown all the
native protein expressed by the construct to be soluble, we found that
virtually all of the SeMet-BipD was insoluble.
At this point, we used small trial cultures to experiment with a
protocol to avoid the formation of inclusion bodies. This involved
giving the cells a 25 min heat shock at 315 K followed by cooling on
ice for 5 min and induction with a low concentration of IPTG
(0.3 mM). To adapt this method for expression of SeMet protein, we
followed the protocol for selenomethionine incorporation up to the
point where the cells would have otherwise been induced and instead
they were subjected to the above heat shock, cooling and induction.
The cells were then grown at a low temperature (289 K) for 2 d and,
as a precaution against oxidation of the SeMet-BipD, dithiothreitol
(DTT) was included in the buffer used for sonication. SDS–PAGE
gels showed that most of the protein was present in the soluble
fraction, thus conﬁrming the success of the method. The SeMet-
protein was then expressed using 2  1 l cultures for puriﬁcation of
larger quantities for crystallization trials.
A crude initial puriﬁcation of the SeMet-BipD by fractional
ammonium sulfate precipitation was undertaken in which the
ammonium sulfate concentration was raised to 30% saturation to
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protein. The resuspended pellet was then dialysed against 50 mM Tris
buffer pH 8.0 (1 mM DTT) prior to loading onto a GSTrap FF (GE
Healthcare) 5 ml afﬁnity column via an AKTA prime low-pressure
system. The column was washed with phosphate-buffered saline
(PBS) pH 8.0 and 1 mM DTT to remove impurities and the SeMet-
BipD was cleaved from its fusion partner (GST) by addition of 1.6 mg
of thrombin to the column and incubation for 20 h. The column was
then washed with PBS buffer to remove the SeMet-BipD and was
regenerated by washing with reduced glutathione toremove the GST-
fusion partner. The thrombin was removed from the SeMet-BipD by
passage through a 1 ml benzamidine column (GE Healthcare). At all
stages, the purity of the protein and success of the cleavage reaction
was conﬁrmed by SDS–PAGE. The ﬁnal yield of SeMet protein was
approximately 30 mg per litre of culture.
For crystallization experiments, SeMet-BipD was concentrated to
6m gm l
1 using a Vivaspin ultraﬁltration spin column. Screening
conditions were based on those used previously to obtain crystals of
the native enzyme and were set up by the hanging-drop method.
Within 2–3 weeks promising crystals of SeMet-BipD were obtained
and following optimization of the crystallization conditions, signiﬁ-
cantly improved crystals were obtained under the following condi-
tions: SeMet-BipD concentration 4 mg ml
1, 20–25% PEG 4000,
5m Mnickel chloride, 0.1 Mglycine, 0.1 Msodium cacodylate pH 5.0–
5.5. Crystals of up to 1 mm in length grew within a period of four
weeks (Fig. 1) and were ﬂash-frozen as for the native enzyme.
3. X-ray diffraction analysis of BipD
The native and selenomethionyl-BipD crystals were taken to the
European Synchrotron Radiation Facility (ESRF, Grenoble). A
native crystal was found to diffract to a resolution of around 2.5 A ˚
and larger SeMet-BipD crystals diffracted to a resolution of 2.1 A ˚
(Fig. 2). Processing of the data sets using MOSFLM (Leslie, 2006),
SCALA (Evans, 2006) and other programs from the CCP4 program
suite (Collaborative Computational Project, Number 4, 1994) indi-
cated that the crystals belonged to the monoclinic space group P21.
The selenomethionyl-BipD crystal had unit-cell parameters a = 53.5,
b = 56.2, c= 84.2 A ˚ , = 94.5 and the lower resolution native data set
yielded very similar values (Table 1). The processed selenomethionyl-
BipD data set extends to 2.1 A ˚ resolution with an overall Rmerge of
8.6%, a completeness of 97.5% and a multiplicity of 3.7. The native
data set to 2.5 A ˚ resolution had an Rmerge of 5.6%, a completeness of
99.0% and a multiplicity of 3.7. Use of the MC program (Colla-
borative Computational Project, Number 4, 1994) suggests that the
crystals are likely to have either one BipD monomer (of 33 kDa) per
asymmetric unit, corresponding to a solvent content of 68%, or two
monomers per asymmetric unit, with a solvent content of 35%.
Analysis of the structure is currently in progress.
We thank the Wellcome Trust for infrastructure support and a
vacation scholarship to MJK. We are indebted to the ESRF
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